You just read:

SELLAS™ Life Sciences Receives FDA Fast Track Designation of Galinpepimut-S for the Treatment of Malignant Pleural Mesothelioma

News provided by

SELLAS Life Sciences Group

Sep 19, 2016, 09:30 ET